{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-023779","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2023-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.712250+00:00","generated_at":"2026-06-19T06:43:24.881460+00:00","sec_items":["4.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Aytu BioPharma restates Q1 FY2023 financials; warrant misclassification adds $5.6M liabilities","bullets":["Audit committee concludes Sep 30, 2022 financials should be restated due to warrant misclassification as equity instead of liabilities.","Restatement increases total liabilities by $5.6M, decreases equity by $3.4M, and reduces net loss by $2.2M.","Material weakness in internal control over financial reporting identified; company working to remediate.","Company expects to file 10-Q/A for Sep quarter and then 10-Q for Dec quarter as soon as practicable.","Going forward, warrants will be classified as liabilities, which may adversely affect results of operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-023779","json":"https://secwatch.observer/filing/0001104659-23-023779.json","markdown":"https://secwatch.observer/filing/0001104659-23-023779.md","text":"https://secwatch.observer/filing/0001104659-23-023779.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000110465923023779/0001104659-23-023779-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000110465923023779/tm237439d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T06:43:24.881460+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d550fe575e3dceae9aafb02270dd1fe1e2d0cf19","claim":"AYTU BIOPHARMA, INC reported that prior financial statements should not be relied upon.","evidence_excerpt":"and, accordingly, that such previously issued financial statements should no longer be relied upon","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1385818/000110465923023779/0001104659-23-023779-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"non reliance"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}